Health

Promoted content
01-12-2017

FEDIOL perspective – Hydrogenation in the context of the debate on Trans Fatty Acids (TFA)

FEDIOL supports the introduction of an EU-wide 2% non-ruminant TFA legal limit on fat basis in products intended to the final consumers together with the deletion of the existing full/partial hydrogenation labelling as prescribed by Regulation (EU) No 1169/2011.
Promoted content
13-11-2017

Place your bets: FTI Consulting’s EMA relocation game

Download PDF  

The EU vote on 20 November will decide the new location of the European Medicines Agency (EMA), one of the big Brexit prizes.
Promoted content
12-10-2017

Increasing access to medicines: Better care for more patients

Download PDF  

Due to austerity measures and weak growth, our ageing populations and rising healthcare costs driven by new, expensive treatments, European healthcare faces unprecedented and growing pressures.
Promoted content
Soft drinks industry to reduce added sugars a further 10% by 2020
15-05-2017

Soft drinks industry to reduce added sugars a further 10% by 2020

Download PDF  

The European soft drinks industry has been on a sugar reduction journey since the 1970's and the introduction of the first no calorie drinks.
Promoted content
Rare Diseases in the EU
29-02-2016

INFOGRAPHIC: Rare diseases in the EU

Rare diseases affect more than 30 million Europeans, many of whom are children! What is the European Union doing about it?
Promoted content
Familial hypercholesterolemia
15-12-2015

INFOGRAPHIC: Call to action on Familial Hypercholesterolemia (FH)

MEPs and patient organisations call EU to action on Familial Hypercholesterolemia (FH), a genetic disease characterised by high levels of the 'bad' cholesterol in the patients.
Promoted content
27-11-2015

INFOGRAPHIC: Knowledge of cardiovascular disease in the European Parliament

Knowledge of cardiovascular disease among members of the European Parliament is fairly low, according to a survey by ComRes.
Promoted content
06-10-2015

Significant and Enduring Burden of Cardiovascular Disease in Europe

Cardiovascular disease (CVD) is the leading cause of death among women and men in Europe, causing over 4.35 million deaths each year in the 53 member states of the World Health Organization European Region and more than 1.9 million deaths each year in the European Union
Special ReportPromoted content
Getting Europe Moving
18-06-2015

Getting Europe Moving

A new study shows the costs of ‘doing nothing’: the inactivity time bomb is killing 500,000 Europeans, and costing over € 80 billion per year. ISCA (International Sport & Culture Association) is campaignin to get 100 million Europeans to move more by 2020. Read the full report and find out what you can do to help get Europe moving at http://inactivity-time-bomb.nowwemove.com.
Promoted content
Infographic: ?Familial Hypercholesterolemia
19-03-2015

Familial Hypercholesterolemia

What is FH? FH is an inherited condition associated with high “bad” cholesterol (low-density lipoprotein-cholesterol or LDL-C) and may predispose a person to premature cardiovascular disease (CVD). People with FH are unable to process the body’s natural supply of cholesterol, leading to very high levels of “bad” cholesterol that can block arteries and lead to a heart attack or stroke.
Special ReportPromoted content
Development Policy 26-02-2015

INFOGRAPHIC: Vaccine R&D leaders

Vaccination may be the most effective public health intervention of all time. This is especially true in developing countries, where many families can’t find or afford health care when they get sick. The prevention offered by vaccines can be life-saving.
Promoted content
Infographic: Europe's Cancer Challenge
20-02-2015

Europe’s Cancer Challenge

Cancer is the second most common cause of death in the European Union. New approaches are urgently needed to address the growing number of cancer cases diagnosed each year.